250 related articles for article (PubMed ID: 21358115)
1. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
[TBL] [Abstract][Full Text] [Related]
2. Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma.
Kihara M; Miyauchi A; Kudo T; Hirokawa M; Miya A
Endocr J; 2016 Jul; 63(7):627-32. PubMed ID: 27097651
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.
Lorenz K; Elwerr M; Machens A; Abuazab M; Holzhausen HJ; Dralle H
Langenbecks Arch Surg; 2013 Mar; 398(3):403-9. PubMed ID: 23408061
[TBL] [Abstract][Full Text] [Related]
4. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
6. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
7. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
10. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
Kartal Baykan E; Erdoğan M
Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
12. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.
Mian C; Perrino M; Colombo C; Cavedon E; Pennelli G; Ferrero S; De Leo S; Sarais C; Cacciatore C; Manfredi GI; Verga U; Iacobone M; De Pasquale L; Pelizzo MR; Vicentini L; Persani L; Fugazzola L
J Clin Endocrinol Metab; 2014 May; 99(5):1656-64. PubMed ID: 24552221
[TBL] [Abstract][Full Text] [Related]
13. [Calcitonin determination for early diagnosis of medullary thyroid cancer].
Karges W
Chirurg; 2010 Jul; 81(7):620, 622-6. PubMed ID: 20549176
[TBL] [Abstract][Full Text] [Related]
14. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
15. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
16. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
[TBL] [Abstract][Full Text] [Related]
17. [Recommendation for Calcitonin Screening in Nodular Goiter].
Frank-Raue K; Schott M; Raue F;
Dtsch Med Wochenschr; 2018 Aug; 143(15):1065-1069. PubMed ID: 30060274
[TBL] [Abstract][Full Text] [Related]
18. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of calcitonin stimulation test using calcium gluconate and pentagastrin and the usefulness of procalcitonin basic and post-stimulation concentrations in the diagnosis of patients after surgery for medullary.
Kowalska A; Lizis-Kolus K; Gąsior-Perczak D; Palyga I; Słuszniak A; Słuszniak J; Antczak G; Lizis P; Mezyk R; Gozdz S
Neuro Endocrinol Lett; 2016 Dec; 37(7):485-490. PubMed ID: 28326742
[TBL] [Abstract][Full Text] [Related]
20. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
